Clinical Trial Update: Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluates acceptable hemodynamic changes after a single intravenous bolus injection of dexmedetomidine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Postoperative Complications

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Delirium, Postoperative Complications | Phase 4 | Status: UNKNOWN